Saved Bookmarks
| 1. |
Which of the following statements refers to gallium nitrate: a) It is approved by the FDA for the management of hypercalcemia of malignancy b) This drug acts by inhibiting bone resorption c) Because of potential nephrotoxicity, patients should be well-hydrated and have good renal output before starting the infusion d) All of the above |
|
Answer» d) All of the above |
|